SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : NEOTHERAPEUTICS (NEOT) (NEOTW)
NEOT 1.919+4.3%Jan 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: john jansen who wrote (600)11/18/1998 12:45:00 PM
From: Marty  Read Replies (1) of 705
 
I'm not so sure the WSJ is interested in hearing from someone who doesn't speak for the Company. I am also not so sure I want an article at this time just because just now, in my own case, I am accumulating more at the lowest prices I can. I think this is a time to accumulate more before phase 2 results are out. If there had been any bad news in the tests, we would know it by now. They are required to announce it right away and that hasn't happened. I expect when the analysis comes out, it will be clear that this is truly a breakthrough drug. This time they can talk about efficacy and how well it worked and not just talk about toxicity and how well it was absorbed.

Usually I hate it when nothing new is announced and the price just drifts down, but for purely personal reasons, and only for the moment, I am not concerned. I'm long and going longer because everything about the drug so far has been better than expected. If that alone was all that mattered, the price would a lot higher. As you suggest, the story has to be told even better ... some day.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext